Jared Klarquist
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 11 | 2025 | 917 | 2.090 |
Why?
| | B-Lymphocytes | 5 | 2025 | 847 | 1.740 |
Why?
| | T-Lymphocytes, Helper-Inducer | 4 | 2021 | 137 | 1.500 |
Why?
| | Immunologic Memory | 4 | 2025 | 369 | 1.460 |
Why?
| | Lupus Erythematosus, Systemic | 4 | 2020 | 257 | 1.450 |
Why?
| | Vitiligo | 8 | 2016 | 42 | 1.370 |
Why?
| | Vaccines, Subunit | 2 | 2021 | 49 | 1.300 |
Why?
| | T-Lymphocytes, Regulatory | 6 | 2025 | 392 | 0.870 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2021 | 107 | 0.830 |
Why?
| | Interleukin-27 | 1 | 2021 | 13 | 0.740 |
Why?
| | Interferon Type I | 2 | 2020 | 142 | 0.720 |
Why?
| | Skin | 5 | 2016 | 751 | 0.710 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2021 | 187 | 0.660 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 5792 | 0.650 |
Why?
| | gp100 Melanoma Antigen | 3 | 2016 | 8 | 0.610 |
Why?
| | Chemokine CCL22 | 1 | 2016 | 3 | 0.530 |
Why?
| | Dendritic Cells | 4 | 2016 | 488 | 0.520 |
Why?
| | Melanoma | 5 | 2016 | 758 | 0.510 |
Why?
| | Mice | 20 | 2025 | 17843 | 0.470 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4295 | 0.460 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2016 | 720 | 0.460 |
Why?
| | Lymphangioleiomyomatosis | 2 | 2013 | 35 | 0.420 |
Why?
| | Autoimmunity | 3 | 2025 | 907 | 0.400 |
Why?
| | Animals | 23 | 2025 | 37011 | 0.400 |
Why?
| | Mice, Knockout | 9 | 2025 | 3020 | 0.390 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 433 | 0.370 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 2011 | 173 | 0.350 |
Why?
| | T-Lymphocytes | 2 | 2018 | 1999 | 0.340 |
Why?
| | Membrane Glycoproteins | 2 | 2010 | 501 | 0.330 |
Why?
| | Melanocytes | 5 | 2014 | 66 | 0.310 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2009 | 225 | 0.310 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2021 | 1092 | 0.300 |
Why?
| | T-Lymphocyte Subsets | 4 | 2014 | 425 | 0.290 |
Why?
| | Membrane Proteins | 1 | 2014 | 1167 | 0.290 |
Why?
| | Germinal Center | 2 | 2020 | 58 | 0.280 |
Why?
| | Vaccination | 4 | 2021 | 1398 | 0.280 |
Why?
| | DNA | 1 | 2014 | 1460 | 0.280 |
Why?
| | Hepatitis C | 5 | 2008 | 263 | 0.280 |
Why?
| | Antigens, Neoplasm | 1 | 2009 | 322 | 0.270 |
Why?
| | Hepacivirus | 5 | 2008 | 258 | 0.260 |
Why?
| | Up-Regulation | 4 | 2018 | 846 | 0.250 |
Why?
| | Hepatitis C, Chronic | 4 | 2008 | 164 | 0.240 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 27 | 0.240 |
Why?
| | Gangliosides | 2 | 2016 | 20 | 0.240 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 33 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.230 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 91 | 0.230 |
Why?
| | Th17 Cells | 1 | 2025 | 109 | 0.220 |
Why?
| | Receptors, CCR4 | 2 | 2016 | 22 | 0.210 |
Why?
| | Flow Cytometry | 5 | 2017 | 1185 | 0.210 |
Why?
| | Interleukin-15 | 2 | 2025 | 97 | 0.200 |
Why?
| | Lysophospholipids | 1 | 2023 | 80 | 0.200 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 257 | 0.200 |
Why?
| | Colon | 1 | 2025 | 280 | 0.200 |
Why?
| | Colitis | 1 | 2025 | 265 | 0.190 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 621 | 0.190 |
Why?
| | Phenols | 3 | 2014 | 101 | 0.180 |
Why?
| | Lymphocyte Count | 1 | 2021 | 150 | 0.180 |
Why?
| | Receptors, Virus | 1 | 2021 | 83 | 0.180 |
Why?
| | HSP70 Heat-Shock Proteins | 2 | 2014 | 74 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 8 | 0.170 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2182 | 0.170 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 34 | 0.160 |
Why?
| | Humans | 30 | 2025 | 137514 | 0.160 |
Why?
| | Neoplasms | 1 | 2014 | 2666 | 0.160 |
Why?
| | Transcriptional Activation | 2 | 2018 | 379 | 0.150 |
Why?
| | Aerobiosis | 1 | 2018 | 21 | 0.150 |
Why?
| | Female | 18 | 2025 | 73162 | 0.150 |
Why?
| | Vaccinia | 1 | 2018 | 21 | 0.150 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 454 | 0.150 |
Why?
| | Ovalbumin | 1 | 2018 | 183 | 0.150 |
Why?
| | Orthomyxoviridae Infections | 1 | 2018 | 75 | 0.140 |
Why?
| | Antiviral Agents | 3 | 2008 | 740 | 0.140 |
Why?
| | Receptors, Interleukin-17 | 1 | 2017 | 5 | 0.140 |
Why?
| | B7-H1 Antigen | 2 | 2018 | 218 | 0.140 |
Why?
| | Cells, Cultured | 4 | 2020 | 4206 | 0.140 |
Why?
| | Adjuvants, Immunologic | 1 | 2018 | 226 | 0.130 |
Why?
| | Sialyltransferases | 1 | 2016 | 13 | 0.130 |
Why?
| | Housing, Animal | 1 | 2017 | 46 | 0.130 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2018 | 171 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2008 | 188 | 0.130 |
Why?
| | Male | 16 | 2025 | 67718 | 0.130 |
Why?
| | Interleukins | 1 | 2018 | 251 | 0.130 |
Why?
| | Killer Cells, Natural | 1 | 2020 | 446 | 0.130 |
Why?
| | Glycolysis | 1 | 2018 | 319 | 0.130 |
Why?
| | Macrophages, Peritoneal | 1 | 2016 | 94 | 0.130 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 88 | 0.130 |
Why?
| | Stress, Physiological | 2 | 2017 | 445 | 0.130 |
Why?
| | Epidermis | 2 | 2014 | 157 | 0.130 |
Why?
| | Melanoma, Experimental | 1 | 2016 | 113 | 0.120 |
Why?
| | Jurkat Cells | 1 | 2016 | 134 | 0.120 |
Why?
| | Diet, High-Fat | 1 | 2017 | 248 | 0.120 |
Why?
| | CD8 Antigens | 1 | 2015 | 75 | 0.120 |
Why?
| | Intramolecular Oxidoreductases | 3 | 2011 | 68 | 0.120 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.120 |
Why?
| | Cell Death | 2 | 2014 | 370 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2025 | 2482 | 0.120 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2018 | 202 | 0.120 |
Why?
| | Allergens | 1 | 2018 | 407 | 0.120 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 274 | 0.120 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2014 | 17 | 0.120 |
Why?
| | Cloning, Molecular | 1 | 2016 | 536 | 0.120 |
Why?
| | Plaque, Atherosclerotic | 1 | 2015 | 57 | 0.120 |
Why?
| | Hyperlipidemias | 1 | 2015 | 120 | 0.110 |
Why?
| | Hypopigmentation | 1 | 2014 | 3 | 0.110 |
Why?
| | Antigens, CD | 2 | 2008 | 524 | 0.110 |
Why?
| | Skin Pigmentation | 3 | 2011 | 49 | 0.110 |
Why?
| | Base Sequence | 2 | 2016 | 2180 | 0.110 |
Why?
| | B-Lymphocyte Subsets | 1 | 2014 | 75 | 0.110 |
Why?
| | Pigmentation | 1 | 2014 | 52 | 0.110 |
Why?
| | Hydroquinones | 2 | 2014 | 29 | 0.110 |
Why?
| | Temperature | 1 | 2017 | 680 | 0.110 |
Why?
| | Mutation | 1 | 2025 | 3964 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 278 | 0.110 |
Why?
| | Immunity | 1 | 2014 | 145 | 0.110 |
Why?
| | Oxidoreductases | 2 | 2011 | 93 | 0.100 |
Why?
| | Antigens | 1 | 2014 | 358 | 0.100 |
Why?
| | Skin Neoplasms | 2 | 2011 | 853 | 0.100 |
Why?
| | Interferon-gamma | 4 | 2008 | 790 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1402 | 0.090 |
Why?
| | HSP72 Heat-Shock Proteins | 1 | 2011 | 32 | 0.090 |
Why?
| | Neoplasms, Experimental | 1 | 2012 | 176 | 0.090 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2012 | 210 | 0.090 |
Why?
| | Atherosclerosis | 1 | 2015 | 415 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 849 | 0.090 |
Why?
| | Heme Oxygenase-1 | 1 | 2011 | 64 | 0.090 |
Why?
| | Signal Transduction | 3 | 2025 | 5096 | 0.090 |
Why?
| | Ribavirin | 2 | 2008 | 91 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1507 | 0.090 |
Why?
| | Receptors, CCR8 | 1 | 2010 | 2 | 0.080 |
Why?
| | Sepsis | 1 | 2016 | 611 | 0.080 |
Why?
| | Forkhead Transcription Factors | 2 | 2008 | 191 | 0.080 |
Why?
| | Interferon-alpha | 2 | 2008 | 198 | 0.080 |
Why?
| | MART-1 Antigen | 1 | 2009 | 12 | 0.080 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 98 | 0.080 |
Why?
| | Receptors, CCR5 | 1 | 2010 | 59 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2009 | 153 | 0.080 |
Why?
| | Macrophages | 1 | 2016 | 1548 | 0.080 |
Why?
| | Immunotherapy, Adoptive | 1 | 2012 | 324 | 0.070 |
Why?
| | Cell Separation | 1 | 2009 | 320 | 0.070 |
Why?
| | Convalescence | 1 | 2007 | 18 | 0.070 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 459 | 0.070 |
Why?
| | Interleukin-2 | 2 | 2025 | 456 | 0.070 |
Why?
| | Disease Transmission, Infectious | 1 | 2007 | 61 | 0.070 |
Why?
| | Adult | 9 | 2016 | 37821 | 0.070 |
Why?
| | RNA, Viral | 3 | 2024 | 653 | 0.070 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2006 | 12 | 0.070 |
Why?
| | Receptors, Interleukin-7 | 1 | 2006 | 28 | 0.070 |
Why?
| | Epitopes | 3 | 2015 | 481 | 0.060 |
Why?
| | Polyethylene Glycols | 2 | 2008 | 640 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1279 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 57 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 43 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1740 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.060 |
Why?
| | Immunotherapy | 1 | 2009 | 647 | 0.060 |
Why?
| | Obesity | 1 | 2017 | 2974 | 0.050 |
Why?
| | Inflammation | 3 | 2025 | 2837 | 0.050 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 23 | 0.050 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2023 | 30 | 0.050 |
Why?
| | Middle Aged | 9 | 2014 | 33355 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 974 | 0.050 |
Why?
| | Listeria monocytogenes | 1 | 2023 | 126 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2013 | 2494 | 0.040 |
Why?
| | Adolescent | 4 | 2014 | 21555 | 0.040 |
Why?
| | Cell Survival | 2 | 2014 | 1122 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 947 | 0.040 |
Why?
| | Jejunum | 1 | 2017 | 31 | 0.030 |
Why?
| | Young Adult | 2 | 2014 | 13243 | 0.030 |
Why?
| | Th1 Cells | 2 | 2008 | 143 | 0.030 |
Why?
| | Sex Factors | 2 | 2017 | 2074 | 0.030 |
Why?
| | Biolistics | 1 | 2016 | 2 | 0.030 |
Why?
| | Gram-Negative Bacteria | 1 | 2017 | 75 | 0.030 |
Why?
| | Permeability | 1 | 2017 | 162 | 0.030 |
Why?
| | Cytokines | 1 | 2025 | 2095 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 37 | 0.030 |
Why?
| | Viremia | 2 | 2008 | 138 | 0.030 |
Why?
| | Vaccines, DNA | 1 | 2016 | 32 | 0.030 |
Why?
| | Cytomegalovirus | 2 | 2007 | 160 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2016 | 3420 | 0.030 |
Why?
| | Corticosterone | 1 | 2017 | 237 | 0.030 |
Why?
| | Cold Temperature | 1 | 2017 | 177 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2838 | 0.030 |
Why?
| | Receptors, LDL | 1 | 2015 | 49 | 0.030 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 42 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 1979 | 0.030 |
Why?
| | Disease Progression | 2 | 2017 | 2755 | 0.030 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2008 | 252 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1717 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2014 | 8 | 0.030 |
Why?
| | Stem Cell Factor | 1 | 2014 | 15 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2016 | 373 | 0.030 |
Why?
| | Alleles | 2 | 2008 | 891 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 313 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2015 | 216 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2008 | 1357 | 0.030 |
Why?
| | Acute Disease | 2 | 2008 | 1008 | 0.030 |
Why?
| | Melanosomes | 1 | 2014 | 2 | 0.030 |
Why?
| | Trans-Activators | 1 | 2016 | 399 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 2014 | 82 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 734 | 0.030 |
Why?
| | Hematopoietic Stem Cells | 1 | 2017 | 398 | 0.030 |
Why?
| | Intracellular Space | 1 | 2014 | 69 | 0.030 |
Why?
| | Interleukin-17 | 1 | 2014 | 120 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 180 | 0.030 |
Why?
| | Spleen | 1 | 2015 | 516 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 68 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2016 | 646 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 886 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2013 | 3546 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2015 | 493 | 0.020 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.020 |
Why?
| | HLA-A2 Antigen | 1 | 2012 | 48 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2016 | 778 | 0.020 |
Why?
| | Protein Transport | 1 | 2014 | 443 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2015 | 425 | 0.020 |
Why?
| | CD3 Complex | 1 | 2012 | 106 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1255 | 0.020 |
Why?
| | Machine Learning | 1 | 2017 | 496 | 0.020 |
Why?
| | Bleaching Agents | 1 | 2011 | 1 | 0.020 |
Why?
| | PUVA Therapy | 1 | 2011 | 6 | 0.020 |
Why?
| | Langerhans Cells | 1 | 2011 | 12 | 0.020 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2011 | 22 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 957 | 0.020 |
Why?
| | Administration, Topical | 1 | 2011 | 149 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 2008 | 2857 | 0.020 |
Why?
| | Annexin A5 | 1 | 2010 | 25 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2010 | 42 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1770 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 156 | 0.020 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2010 | 99 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 696 | 0.020 |
Why?
| | Necrosis | 1 | 2010 | 244 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 246 | 0.020 |
Why?
| | Autoantigens | 1 | 2011 | 429 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 265 | 0.020 |
Why?
| | Cell Line | 1 | 2014 | 2852 | 0.020 |
Why?
| | Keratinocytes | 1 | 2010 | 248 | 0.020 |
Why?
| | Ultraviolet Rays | 1 | 2011 | 389 | 0.020 |
Why?
| | Fibrinogens, Abnormal | 1 | 2008 | 4 | 0.020 |
Why?
| | CD24 Antigen | 1 | 2008 | 20 | 0.020 |
Why?
| | Remission, Spontaneous | 1 | 2007 | 40 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 84 | 0.020 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2007 | 15 | 0.020 |
Why?
| | CD57 Antigens | 1 | 2007 | 18 | 0.020 |
Why?
| | Genes, MHC Class II | 1 | 2007 | 74 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 413 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2007 | 141 | 0.020 |
Why?
| | Cohort Studies | 2 | 2008 | 5730 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 577 | 0.020 |
Why?
| | Blood | 1 | 2007 | 106 | 0.020 |
Why?
| | Age Distribution | 1 | 2007 | 391 | 0.020 |
Why?
| | HLA Antigens | 1 | 2008 | 237 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2008 | 203 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 403 | 0.020 |
Why?
| | Immunoglobulin M | 1 | 2007 | 288 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2008 | 268 | 0.020 |
Why?
| | Viral Load | 1 | 2007 | 462 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2008 | 7593 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 379 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 2007 | 194 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2008 | 1060 | 0.010 |
Why?
| | Prospective Studies | 2 | 2008 | 7598 | 0.010 |
Why?
| | Fibroblasts | 1 | 2010 | 990 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1061 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2011 | 1307 | 0.010 |
Why?
| | RNA | 1 | 2011 | 924 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2007 | 623 | 0.010 |
Why?
| | Sexual Behavior | 1 | 2007 | 487 | 0.010 |
Why?
| | Genotype | 1 | 2008 | 1920 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2039 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2014 | 6059 | 0.010 |
Why?
| | Apoptosis | 1 | 2010 | 2557 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2007 | 1428 | 0.010 |
Why?
| | Lung | 1 | 2013 | 4066 | 0.010 |
Why?
| | Liver | 1 | 2007 | 1940 | 0.010 |
Why?
| | Biomarkers | 1 | 2010 | 4172 | 0.010 |
Why?
| | Phenotype | 1 | 2006 | 3205 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 5772 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 10821 | 0.010 |
Why?
| | Risk Factors | 1 | 2007 | 10356 | 0.010 |
Why?
| | United States | 1 | 2007 | 14696 | 0.010 |
Why?
| | Aged | 1 | 2007 | 23798 | 0.000 |
Why?
|
|
Klarquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|